From Surf Wiki (app.surf) — the open knowledge base
Breast MRI
Form of breast imaging
Form of breast imaging
| Field | Value | |
|---|---|---|
| Name | Breast MRI | |
| Image | Mri of breast cancer.jpg | |
| Caption | Breast MRI demonstrating marked enhancement (bright area) which was confirmed to be cancer. | |
| ICD10 | BH3 | |
| ICD9 | , | |
| MeshID | ||
| OPS301 | ||
| OtherCodes |
Name =Breast MRI| Image =Mri of breast cancer.jpg| Caption =Breast MRI demonstrating marked enhancement (bright area) which was confirmed to be cancer.| ICD10 =BH3| ICD9 =, | MeshID =| OPS301 =| OtherCodes=| One alternative to mammography, **breast MRI ** or contrast-enhanced magnetic resonance imaging (MRI), has shown substantial progress in the detection of breast cancer.
Uses
Some of the uses of MRI of the breasts are: screening for malignancy in women with greater than 20% lifetime risk of breast cancer (especially those with high risk genes such as BRCA1 and BRCA2), evaluate breast implants for rupture, screening the opposite side breast for malignancy in women with known one sided breast malignancy, extent of disease and the presence of multifocality and multicentricity in patients with invasive carcinoma and ductal carcinoma in situ (DCIS), and evaluate response to neoadjuvant chemotherapy.
MRI of the breasts has the highest sensitivity to detect breast cancer when compared with other imaging modalities such as breast ultrasound or mammography. In the screening for breast cancer for high-risk women, sensitivity of MRI ranges from 83 to 94% while specificity (the confidence that a lesion is cancerous and not a false positive) ranges from 75.2% to 100%.
Nephrogenic systemic fibrosis
The systemic disease nephrogenic systemic fibrosis (NSF), caused by exposure to gadolinium in MRI contrast agents, resembles scleromyxedema and to some extent scleroderma. It may occur months after contrast has been injected. Patients with poorer kidney function are more at risk for NSF, with dialysis patients being more at risk than patients with chronic kidney disease. After several years of controversy during which up to 100 Danish patients have been gadolinium poisoned (and some died) after use of the contrast agent Omniscan, the Norwegian medical company Nycomed admitted that they were aware of some dangers of using gadolinium-based agents for their product. At present, NSF has been linked to the use of four gadolinium-containing MRI contrast agents.
References
References
- (September 2019). "Breast MRI: State of the Art". Radiology.
- (2013). "ACR Practice Parameter for the Performance of Contrast-Enhanced Magnetic Resonance Imaging (MRI) of the Breast". [[American College of Radiology]].
- (2001). "Magnetic Resonance Imaging of the Breast". Cancer Control.
- "Medicinalfirma fortiede at stof var farligt".
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Breast MRI — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report